News | November 05, 2008

AtCor Introduces New, Portable Systems to Measure Central Blood Pressure, Pulse Wave Velocity, Heart Rate

November 6, 2008 - AtCor Medical Inc. today introduced the new, lightweight, portable SphygmoCor CP, SphygmoCor CPV and SphygmoCor CPVH systems at Renal Week 2008, the annual scientific meeting of the American Society of Nephrology, Nov. 6-8 and the American Heart Association Scientific Sessions Nov. 9-12.

The company’s SphgymoCor technology is used for noninvasive central blood pressure and pulse wave velocity assessment. SphygmoCor technology is in use in leading medical centers and in clinical trials worldwide, the maker said.

AtCor Medical developed its new, more compact SphygmoCor systems, available in different configurations, to make assessing central blood pressure, pulse wave velocity and heart rate variability easier and more convenient in settings where space is at a premium - at bedside in hospitals, in patient exam rooms in physicians’ offices, ERs, mobile patient screening vans, and in home care. All three tests are used in evaluating cardiovascular status and in managing patient care.

The new SphygmoCor systems, approximately 25 percent the size and weight of AtCor’s first generation systems, offer the same functionality as the earlier SphgymoCor Px and Vx systems with added portability, less power consumption and enhanced electronics. The SphygmoCor CPV system, which performs both central blood pressure and pulse wave velocity assessments, can be also be configured to perform heart rate variability analyses, a new system capability. Heart rate variability testing is used in assessing cardiovascular risk.

A large recently published clinical study found 70 percent of patients with high normal blood pressure had central blood pressures equivalent with those of patients diagnosed with stage one hypertension. Others studies have shown that elevated central pressure is associated with increased risk of heart attack, stroke and kidney disease. Elevated central blood pressure is called a silent killer, because it may go undetected with traditional cuff blood pressure measurements, and studies show it is more than 50 percent more effective as a predictor of cardiovascular events, the company said.

More than 1,700 SphygmoCor systems are currently in use worldwide at major medical institutions, research institutions and in various clinical trials with leading pharmaceutical companies.

For more information:

Related Content

Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
monitoring a heart failure patient's chest fluid buildup with remote monitoring using the SensiVest

A heart failure patient wearing the SensiVest remote monitoring system for a two-minute a day assessment. 

News | Heart Failure| July 13, 2017
July 13, 2017 — About 5.7 million adults in the U.S.
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
Ohio State Investigating High-Tech Vest for At-Home Heart Failure Management
News | Heart Failure| June 28, 2017
Doctors at The Ohio State University Richard M. Ross Heart Hospital are testing a high-tech vest that measures fluid...
First Canadian Patient Implanted With CardioMEMS Heart Failure Sensor
News | Heart Failure| June 23, 2017
In a Canadian first, a medical team has implanted the wireless CardioMEMS HF device inside a heart failure patient. The...
Northwell Health Partners With Peerbridge Health on Remote Patient Monitoring
News | Wearable Sensors| June 01, 2017
Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Consumers Warned About Accuracy of Heart Rate Apps in New Study
News | Mobile Devices| May 22, 2017
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability
Acarix, CADScor System, coronary artery disease detection, clinical study, ACC.17
News | Patient Monitors| March 30, 2017
Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive...
Overlay Init